nodes	percent_of_prediction	percent_of_DWPC	metapath
Milnacipran—SLC6A4—ganglion—brain cancer	0.0179	0.144	CbGeAlD
Milnacipran—SLC6A2—ganglion—brain cancer	0.0158	0.127	CbGeAlD
Milnacipran—SLC6A4—hindbrain—brain cancer	0.0136	0.109	CbGeAlD
Milnacipran—SLC6A4—brainstem—brain cancer	0.00778	0.0627	CbGeAlD
Milnacipran—Infection—Carboplatin—brain cancer	0.00759	0.00867	CcSEcCtD
Milnacipran—Leukopenia—Lomustine—brain cancer	0.00733	0.00837	CcSEcCtD
Milnacipran—Angina pectoris—Procarbazine—brain cancer	0.00727	0.0083	CcSEcCtD
Milnacipran—Renal failure acute—Hydroxyurea—brain cancer	0.00724	0.00826	CcSEcCtD
Milnacipran—SLC6A4—telencephalon—brain cancer	0.00691	0.0557	CbGeAlD
Milnacipran—Pollakiuria—Procarbazine—brain cancer	0.00689	0.00787	CcSEcCtD
Milnacipran—SLC6A2—brainstem—brain cancer	0.00685	0.0552	CbGeAlD
Milnacipran—Dry eye—Temozolomide—brain cancer	0.00664	0.00758	CcSEcCtD
Milnacipran—Infection—Lomustine—brain cancer	0.00664	0.00758	CcSEcCtD
Milnacipran—Thrombocytopenia—Lomustine—brain cancer	0.00654	0.00747	CcSEcCtD
Milnacipran—Chest discomfort—Etoposide—brain cancer	0.0065	0.00742	CcSEcCtD
Milnacipran—Anorexia—Lomustine—brain cancer	0.00637	0.00727	CcSEcCtD
Milnacipran—Haematuria—Procarbazine—brain cancer	0.00634	0.00724	CcSEcCtD
Milnacipran—SLC6A2—telencephalon—brain cancer	0.00608	0.049	CbGeAlD
Milnacipran—Body temperature increased—Carboplatin—brain cancer	0.00604	0.0069	CcSEcCtD
Milnacipran—Breast disorder—Hydroxyurea—brain cancer	0.00604	0.00689	CcSEcCtD
Milnacipran—Hallucination—Procarbazine—brain cancer	0.00594	0.00678	CcSEcCtD
Milnacipran—Decreased appetite—Lomustine—brain cancer	0.00581	0.00663	CcSEcCtD
Milnacipran—Hot flush—Temozolomide—brain cancer	0.00558	0.00637	CcSEcCtD
Milnacipran—Flushing—Procarbazine—brain cancer	0.00554	0.00633	CcSEcCtD
Milnacipran—Menopausal symptoms—Temozolomide—brain cancer	0.00553	0.00632	CcSEcCtD
Milnacipran—Thirst—Temozolomide—brain cancer	0.00548	0.00626	CcSEcCtD
Milnacipran—Hyponatraemia—Carmustine—brain cancer	0.00542	0.00619	CcSEcCtD
Milnacipran—Dysuria—Hydroxyurea—brain cancer	0.0054	0.00617	CcSEcCtD
Milnacipran—Neutropenia—Hydroxyurea—brain cancer	0.0054	0.00617	CcSEcCtD
Milnacipran—Chills—Procarbazine—brain cancer	0.00536	0.00612	CcSEcCtD
Milnacipran—Body temperature increased—Lomustine—brain cancer	0.00528	0.00603	CcSEcCtD
Milnacipran—Tension—Procarbazine—brain cancer	0.0051	0.00583	CcSEcCtD
Milnacipran—SLC6A2—gonad—brain cancer	0.00508	0.0409	CbGeAlD
Milnacipran—Liver function test abnormal—Carmustine—brain cancer	0.00499	0.00569	CcSEcCtD
Milnacipran—SLC6A4—midbrain—brain cancer	0.00496	0.04	CbGeAlD
Milnacipran—Tremor—Procarbazine—brain cancer	0.00487	0.00556	CcSEcCtD
Milnacipran—Hepatobiliary disease—Hydroxyurea—brain cancer	0.00487	0.00556	CcSEcCtD
Milnacipran—SLC6A4—spinal cord—brain cancer	0.00484	0.039	CbGeAlD
Milnacipran—Dry skin—Temozolomide—brain cancer	0.00478	0.00546	CcSEcCtD
Milnacipran—SLC6A2—medulla oblongata—brain cancer	0.00478	0.0385	CbGeAlD
Milnacipran—Breast disorder—Temozolomide—brain cancer	0.00472	0.00539	CcSEcCtD
Milnacipran—Syncope—Procarbazine—brain cancer	0.00466	0.00532	CcSEcCtD
Milnacipran—Leukopenia—Procarbazine—brain cancer	0.00465	0.00531	CcSEcCtD
Milnacipran—Hallucination—Hydroxyurea—brain cancer	0.0046	0.00525	CcSEcCtD
Milnacipran—Loss of consciousness—Procarbazine—brain cancer	0.00457	0.00522	CcSEcCtD
Milnacipran—Abdominal distension—Temozolomide—brain cancer	0.00454	0.00519	CcSEcCtD
Milnacipran—Convulsion—Procarbazine—brain cancer	0.0045	0.00514	CcSEcCtD
Milnacipran—Hypertension—Procarbazine—brain cancer	0.00449	0.00512	CcSEcCtD
Milnacipran—Anxiety—Procarbazine—brain cancer	0.00441	0.00504	CcSEcCtD
Milnacipran—Neutropenia—Carmustine—brain cancer	0.00437	0.00498	CcSEcCtD
Milnacipran—SLC6A4—endocrine gland—brain cancer	0.00436	0.0351	CbGeAlD
Milnacipran—Dry mouth—Procarbazine—brain cancer	0.00433	0.00494	CcSEcCtD
Milnacipran—SLC6A4—head—brain cancer	0.0043	0.0347	CbGeAlD
Milnacipran—Vomiting—Lomustine—brain cancer	0.00425	0.00485	CcSEcCtD
Milnacipran—Neutropenia—Temozolomide—brain cancer	0.00422	0.00482	CcSEcCtD
Milnacipran—Dysuria—Temozolomide—brain cancer	0.00422	0.00482	CcSEcCtD
Milnacipran—Infection—Procarbazine—brain cancer	0.00422	0.00481	CcSEcCtD
Milnacipran—Angiopathy—Hydroxyurea—brain cancer	0.00419	0.00479	CcSEcCtD
Milnacipran—Upper respiratory tract infection—Temozolomide—brain cancer	0.00419	0.00479	CcSEcCtD
Milnacipran—Shock—Procarbazine—brain cancer	0.00417	0.00477	CcSEcCtD
Milnacipran—Pollakiuria—Temozolomide—brain cancer	0.00417	0.00476	CcSEcCtD
Milnacipran—Erectile dysfunction—Temozolomide—brain cancer	0.00416	0.00474	CcSEcCtD
Milnacipran—Thrombocytopenia—Procarbazine—brain cancer	0.00415	0.00474	CcSEcCtD
Milnacipran—Chills—Hydroxyurea—brain cancer	0.00415	0.00474	CcSEcCtD
Milnacipran—Tachycardia—Procarbazine—brain cancer	0.00414	0.00473	CcSEcCtD
Milnacipran—Hyperhidrosis—Procarbazine—brain cancer	0.0041	0.00468	CcSEcCtD
Milnacipran—Weight decreased—Temozolomide—brain cancer	0.00408	0.00466	CcSEcCtD
Milnacipran—Urinary tract infection—Carmustine—brain cancer	0.00405	0.00462	CcSEcCtD
Milnacipran—Anorexia—Procarbazine—brain cancer	0.00404	0.00462	CcSEcCtD
Milnacipran—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.00399	0.00455	CcSEcCtD
Milnacipran—Nausea—Lomustine—brain cancer	0.00397	0.00453	CcSEcCtD
Milnacipran—Hypotension—Procarbazine—brain cancer	0.00397	0.00453	CcSEcCtD
Milnacipran—SLC6A4—central nervous system—brain cancer	0.00393	0.0316	CbGeAlD
Milnacipran—Urinary tract infection—Temozolomide—brain cancer	0.00391	0.00446	CcSEcCtD
Milnacipran—Insomnia—Procarbazine—brain cancer	0.00384	0.00438	CcSEcCtD
Milnacipran—SLC6A2—endocrine gland—brain cancer	0.00384	0.0309	CbGeAlD
Milnacipran—Paraesthesia—Procarbazine—brain cancer	0.00381	0.00435	CcSEcCtD
Milnacipran—Hepatobiliary disease—Temozolomide—brain cancer	0.0038	0.00434	CcSEcCtD
Milnacipran—SLC6A2—head—brain cancer	0.00379	0.0305	CbGeAlD
Milnacipran—Somnolence—Procarbazine—brain cancer	0.00377	0.00431	CcSEcCtD
Milnacipran—Hallucination—Carmustine—brain cancer	0.00372	0.00424	CcSEcCtD
Milnacipran—Hypoaesthesia—Carmustine—brain cancer	0.00372	0.00424	CcSEcCtD
Milnacipran—Decreased appetite—Procarbazine—brain cancer	0.00369	0.00421	CcSEcCtD
Milnacipran—Oedema peripheral—Carmustine—brain cancer	0.00368	0.0042	CcSEcCtD
Milnacipran—Connective tissue disorder—Carmustine—brain cancer	0.00367	0.00419	CcSEcCtD
Milnacipran—Fatigue—Procarbazine—brain cancer	0.00366	0.00418	CcSEcCtD
Milnacipran—Constipation—Procarbazine—brain cancer	0.00363	0.00414	CcSEcCtD
Milnacipran—Hepatitis—Temozolomide—brain cancer	0.00361	0.00412	CcSEcCtD
Milnacipran—Leukopenia—Hydroxyurea—brain cancer	0.0036	0.00411	CcSEcCtD
Milnacipran—Hallucination—Temozolomide—brain cancer	0.00359	0.0041	CcSEcCtD
Milnacipran—Hypoaesthesia—Temozolomide—brain cancer	0.00359	0.0041	CcSEcCtD
Milnacipran—Urinary tract disorder—Temozolomide—brain cancer	0.00357	0.00407	CcSEcCtD
Milnacipran—Oedema peripheral—Temozolomide—brain cancer	0.00356	0.00406	CcSEcCtD
Milnacipran—Connective tissue disorder—Temozolomide—brain cancer	0.00355	0.00405	CcSEcCtD
Milnacipran—Urethral disorder—Temozolomide—brain cancer	0.00354	0.00404	CcSEcCtD
Milnacipran—Eye disorder—Carmustine—brain cancer	0.00349	0.00399	CcSEcCtD
Milnacipran—Convulsion—Hydroxyurea—brain cancer	0.00349	0.00398	CcSEcCtD
Milnacipran—Gastrointestinal pain—Procarbazine—brain cancer	0.00347	0.00396	CcSEcCtD
Milnacipran—Flushing—Carmustine—brain cancer	0.00347	0.00396	CcSEcCtD
Milnacipran—SLC6A2—central nervous system—brain cancer	0.00346	0.0279	CbGeAlD
Milnacipran—Erythema multiforme—Temozolomide—brain cancer	0.00341	0.0039	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.0034	0.00388	CcSEcCtD
Milnacipran—Neutropenia—Etoposide—brain cancer	0.00338	0.00385	CcSEcCtD
Milnacipran—Eye disorder—Temozolomide—brain cancer	0.00337	0.00385	CcSEcCtD
Milnacipran—Urticaria—Procarbazine—brain cancer	0.00337	0.00385	CcSEcCtD
Milnacipran—Abdominal pain—Procarbazine—brain cancer	0.00335	0.00383	CcSEcCtD
Milnacipran—Body temperature increased—Procarbazine—brain cancer	0.00335	0.00383	CcSEcCtD
Milnacipran—Cardiac disorder—Temozolomide—brain cancer	0.00335	0.00383	CcSEcCtD
Milnacipran—Flushing—Temozolomide—brain cancer	0.00335	0.00383	CcSEcCtD
Milnacipran—Angiopathy—Temozolomide—brain cancer	0.00328	0.00374	CcSEcCtD
Milnacipran—Mental disorder—Carmustine—brain cancer	0.00327	0.00374	CcSEcCtD
Milnacipran—Infection—Hydroxyurea—brain cancer	0.00326	0.00372	CcSEcCtD
Milnacipran—Mediastinal disorder—Temozolomide—brain cancer	0.00325	0.00372	CcSEcCtD
Milnacipran—Malnutrition—Carmustine—brain cancer	0.00325	0.00371	CcSEcCtD
Milnacipran—Chills—Temozolomide—brain cancer	0.00324	0.0037	CcSEcCtD
Milnacipran—Nervous system disorder—Hydroxyurea—brain cancer	0.00322	0.00368	CcSEcCtD
Milnacipran—Thrombocytopenia—Hydroxyurea—brain cancer	0.00322	0.00367	CcSEcCtD
Milnacipran—Stevens-Johnson syndrome—Etoposide—brain cancer	0.00319	0.00364	CcSEcCtD
Milnacipran—Skin disorder—Hydroxyurea—brain cancer	0.00319	0.00364	CcSEcCtD
Milnacipran—Mental disorder—Temozolomide—brain cancer	0.00316	0.00361	CcSEcCtD
Milnacipran—Malnutrition—Temozolomide—brain cancer	0.00314	0.00359	CcSEcCtD
Milnacipran—Anorexia—Hydroxyurea—brain cancer	0.00313	0.00357	CcSEcCtD
Milnacipran—Hypersensitivity—Procarbazine—brain cancer	0.00313	0.00357	CcSEcCtD
Milnacipran—SLC6A4—brain—brain cancer	0.00312	0.0251	CbGeAlD
Milnacipran—Dysgeusia—Temozolomide—brain cancer	0.00308	0.00351	CcSEcCtD
Milnacipran—Vision blurred—Carmustine—brain cancer	0.00307	0.0035	CcSEcCtD
Milnacipran—Tremor—Carmustine—brain cancer	0.00305	0.00348	CcSEcCtD
Milnacipran—Asthenia—Procarbazine—brain cancer	0.00304	0.00348	CcSEcCtD
Milnacipran—Hepatobiliary disease—Etoposide—brain cancer	0.00304	0.00348	CcSEcCtD
Milnacipran—Pruritus—Procarbazine—brain cancer	0.003	0.00343	CcSEcCtD
Milnacipran—Agitation—Carmustine—brain cancer	0.00299	0.00341	CcSEcCtD
Milnacipran—Vision blurred—Temozolomide—brain cancer	0.00296	0.00338	CcSEcCtD
Milnacipran—Tremor—Temozolomide—brain cancer	0.00295	0.00336	CcSEcCtD
Milnacipran—Dyspnoea—Hydroxyurea—brain cancer	0.00293	0.00334	CcSEcCtD
Milnacipran—Somnolence—Hydroxyurea—brain cancer	0.00292	0.00333	CcSEcCtD
Milnacipran—Leukopenia—Carmustine—brain cancer	0.00291	0.00332	CcSEcCtD
Milnacipran—Diarrhoea—Procarbazine—brain cancer	0.0029	0.00331	CcSEcCtD
Milnacipran—Dyspepsia—Hydroxyurea—brain cancer	0.00289	0.0033	CcSEcCtD
Milnacipran—Agitation—Temozolomide—brain cancer	0.00289	0.0033	CcSEcCtD
Milnacipran—Hypoaesthesia—Etoposide—brain cancer	0.00288	0.00328	CcSEcCtD
Milnacipran—Decreased appetite—Hydroxyurea—brain cancer	0.00285	0.00326	CcSEcCtD
Milnacipran—Urinary tract disorder—Etoposide—brain cancer	0.00285	0.00326	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00284	0.00324	CcSEcCtD
Milnacipran—Urethral disorder—Etoposide—brain cancer	0.00283	0.00323	CcSEcCtD
Milnacipran—Fatigue—Hydroxyurea—brain cancer	0.00283	0.00323	CcSEcCtD
Milnacipran—Convulsion—Carmustine—brain cancer	0.00282	0.00322	CcSEcCtD
Milnacipran—Leukopenia—Temozolomide—brain cancer	0.00281	0.00321	CcSEcCtD
Milnacipran—Hypertension—Carmustine—brain cancer	0.00281	0.00321	CcSEcCtD
Milnacipran—Constipation—Hydroxyurea—brain cancer	0.00281	0.00321	CcSEcCtD
Milnacipran—Dizziness—Procarbazine—brain cancer	0.00281	0.0032	CcSEcCtD
Milnacipran—Palpitations—Temozolomide—brain cancer	0.00278	0.00317	CcSEcCtD
Milnacipran—Chest pain—Carmustine—brain cancer	0.00277	0.00316	CcSEcCtD
Milnacipran—Anxiety—Carmustine—brain cancer	0.00276	0.00315	CcSEcCtD
Milnacipran—SLC6A2—brain—brain cancer	0.00274	0.0221	CbGeAlD
Milnacipran—Erythema multiforme—Etoposide—brain cancer	0.00273	0.00312	CcSEcCtD
Milnacipran—Convulsion—Temozolomide—brain cancer	0.00272	0.00311	CcSEcCtD
Milnacipran—Hypertension—Temozolomide—brain cancer	0.00271	0.0031	CcSEcCtD
Milnacipran—Eye disorder—Etoposide—brain cancer	0.0027	0.00308	CcSEcCtD
Milnacipran—Vomiting—Procarbazine—brain cancer	0.0027	0.00308	CcSEcCtD
Milnacipran—Cardiac disorder—Etoposide—brain cancer	0.00268	0.00306	CcSEcCtD
Milnacipran—Flushing—Etoposide—brain cancer	0.00268	0.00306	CcSEcCtD
Milnacipran—Rash—Procarbazine—brain cancer	0.00268	0.00305	CcSEcCtD
Milnacipran—Dermatitis—Procarbazine—brain cancer	0.00267	0.00305	CcSEcCtD
Milnacipran—Anxiety—Temozolomide—brain cancer	0.00267	0.00304	CcSEcCtD
Milnacipran—Headache—Procarbazine—brain cancer	0.00266	0.00304	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00266	0.00303	CcSEcCtD
Milnacipran—Infection—Carmustine—brain cancer	0.00264	0.00301	CcSEcCtD
Milnacipran—Angiopathy—Etoposide—brain cancer	0.00262	0.00299	CcSEcCtD
Milnacipran—Dry mouth—Temozolomide—brain cancer	0.00262	0.00299	CcSEcCtD
Milnacipran—Mediastinal disorder—Etoposide—brain cancer	0.0026	0.00297	CcSEcCtD
Milnacipran—Thrombocytopenia—Carmustine—brain cancer	0.0026	0.00297	CcSEcCtD
Milnacipran—Body temperature increased—Hydroxyurea—brain cancer	0.0026	0.00296	CcSEcCtD
Milnacipran—Chills—Etoposide—brain cancer	0.00259	0.00296	CcSEcCtD
Milnacipran—Tachycardia—Carmustine—brain cancer	0.00259	0.00296	CcSEcCtD
Milnacipran—Infection—Temozolomide—brain cancer	0.00255	0.00291	CcSEcCtD
Milnacipran—Anorexia—Carmustine—brain cancer	0.00253	0.00289	CcSEcCtD
Milnacipran—Nausea—Procarbazine—brain cancer	0.00252	0.00288	CcSEcCtD
Milnacipran—Nervous system disorder—Temozolomide—brain cancer	0.00252	0.00287	CcSEcCtD
Milnacipran—Thrombocytopenia—Temozolomide—brain cancer	0.00251	0.00287	CcSEcCtD
Milnacipran—Skin disorder—Temozolomide—brain cancer	0.00249	0.00285	CcSEcCtD
Milnacipran—Hypotension—Carmustine—brain cancer	0.00248	0.00283	CcSEcCtD
Milnacipran—Hyperhidrosis—Temozolomide—brain cancer	0.00248	0.00283	CcSEcCtD
Milnacipran—Dysgeusia—Etoposide—brain cancer	0.00246	0.00281	CcSEcCtD
Milnacipran—Anorexia—Temozolomide—brain cancer	0.00245	0.00279	CcSEcCtD
Milnacipran—Hypersensitivity—Hydroxyurea—brain cancer	0.00242	0.00276	CcSEcCtD
Milnacipran—Insomnia—Carmustine—brain cancer	0.0024	0.00274	CcSEcCtD
Milnacipran—Paraesthesia—Carmustine—brain cancer	0.00238	0.00272	CcSEcCtD
Milnacipran—Dyspnoea—Carmustine—brain cancer	0.00237	0.0027	CcSEcCtD
Milnacipran—Somnolence—Carmustine—brain cancer	0.00236	0.00269	CcSEcCtD
Milnacipran—Asthenia—Hydroxyurea—brain cancer	0.00236	0.00269	CcSEcCtD
Milnacipran—Insomnia—Temozolomide—brain cancer	0.00232	0.00265	CcSEcCtD
Milnacipran—Decreased appetite—Carmustine—brain cancer	0.00231	0.00263	CcSEcCtD
Milnacipran—Paraesthesia—Temozolomide—brain cancer	0.0023	0.00263	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Carmustine—brain cancer	0.00229	0.00262	CcSEcCtD
Milnacipran—Dyspnoea—Temozolomide—brain cancer	0.00229	0.00261	CcSEcCtD
Milnacipran—Somnolence—Temozolomide—brain cancer	0.00228	0.0026	CcSEcCtD
Milnacipran—Constipation—Carmustine—brain cancer	0.00227	0.00259	CcSEcCtD
Milnacipran—Dyspepsia—Temozolomide—brain cancer	0.00226	0.00258	CcSEcCtD
Milnacipran—Leukopenia—Etoposide—brain cancer	0.00225	0.00257	CcSEcCtD
Milnacipran—Diarrhoea—Hydroxyurea—brain cancer	0.00225	0.00257	CcSEcCtD
Milnacipran—Decreased appetite—Temozolomide—brain cancer	0.00223	0.00255	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Temozolomide—brain cancer	0.00221	0.00253	CcSEcCtD
Milnacipran—Fatigue—Temozolomide—brain cancer	0.00221	0.00253	CcSEcCtD
Milnacipran—Loss of consciousness—Etoposide—brain cancer	0.00221	0.00252	CcSEcCtD
Milnacipran—Constipation—Temozolomide—brain cancer	0.00219	0.0025	CcSEcCtD
Milnacipran—Convulsion—Etoposide—brain cancer	0.00218	0.00249	CcSEcCtD
Milnacipran—Hypertension—Etoposide—brain cancer	0.00217	0.00248	CcSEcCtD
Milnacipran—Dizziness—Hydroxyurea—brain cancer	0.00217	0.00248	CcSEcCtD
Milnacipran—Gastrointestinal pain—Carmustine—brain cancer	0.00217	0.00248	CcSEcCtD
Milnacipran—Chest pain—Etoposide—brain cancer	0.00214	0.00244	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.00213	0.00243	CcSEcCtD
Milnacipran—Abdominal pain—Carmustine—brain cancer	0.0021	0.0024	CcSEcCtD
Milnacipran—Body temperature increased—Carmustine—brain cancer	0.0021	0.0024	CcSEcCtD
Milnacipran—Gastrointestinal pain—Temozolomide—brain cancer	0.0021	0.0024	CcSEcCtD
Milnacipran—Vomiting—Hydroxyurea—brain cancer	0.00209	0.00238	CcSEcCtD
Milnacipran—Rash—Hydroxyurea—brain cancer	0.00207	0.00236	CcSEcCtD
Milnacipran—Dermatitis—Hydroxyurea—brain cancer	0.00207	0.00236	CcSEcCtD
Milnacipran—Headache—Hydroxyurea—brain cancer	0.00206	0.00235	CcSEcCtD
Milnacipran—Infection—Etoposide—brain cancer	0.00204	0.00233	CcSEcCtD
Milnacipran—Urticaria—Temozolomide—brain cancer	0.00204	0.00233	CcSEcCtD
Milnacipran—Abdominal pain—Temozolomide—brain cancer	0.00203	0.00232	CcSEcCtD
Milnacipran—Body temperature increased—Temozolomide—brain cancer	0.00203	0.00232	CcSEcCtD
Milnacipran—Thrombocytopenia—Etoposide—brain cancer	0.00201	0.00229	CcSEcCtD
Milnacipran—Tachycardia—Etoposide—brain cancer	0.002	0.00229	CcSEcCtD
Milnacipran—Skin disorder—Etoposide—brain cancer	0.00199	0.00228	CcSEcCtD
Milnacipran—Hyperhidrosis—Etoposide—brain cancer	0.00198	0.00227	CcSEcCtD
Milnacipran—Anorexia—Etoposide—brain cancer	0.00196	0.00223	CcSEcCtD
Milnacipran—Hypersensitivity—Carmustine—brain cancer	0.00196	0.00223	CcSEcCtD
Milnacipran—Nausea—Hydroxyurea—brain cancer	0.00195	0.00223	CcSEcCtD
Milnacipran—Hypotension—Etoposide—brain cancer	0.00192	0.00219	CcSEcCtD
Milnacipran—Asthenia—Carmustine—brain cancer	0.0019	0.00217	CcSEcCtD
Milnacipran—Hypersensitivity—Temozolomide—brain cancer	0.00189	0.00216	CcSEcCtD
Milnacipran—Paraesthesia—Etoposide—brain cancer	0.00184	0.0021	CcSEcCtD
Milnacipran—Asthenia—Temozolomide—brain cancer	0.00184	0.0021	CcSEcCtD
Milnacipran—Dyspnoea—Etoposide—brain cancer	0.00183	0.00209	CcSEcCtD
Milnacipran—Somnolence—Etoposide—brain cancer	0.00183	0.00208	CcSEcCtD
Milnacipran—Diarrhoea—Carmustine—brain cancer	0.00182	0.00207	CcSEcCtD
Milnacipran—Pruritus—Temozolomide—brain cancer	0.00182	0.00207	CcSEcCtD
Milnacipran—Decreased appetite—Etoposide—brain cancer	0.00178	0.00204	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Etoposide—brain cancer	0.00177	0.00202	CcSEcCtD
Milnacipran—Fatigue—Etoposide—brain cancer	0.00177	0.00202	CcSEcCtD
Milnacipran—Dizziness—Carmustine—brain cancer	0.00176	0.002	CcSEcCtD
Milnacipran—Constipation—Etoposide—brain cancer	0.00176	0.002	CcSEcCtD
Milnacipran—Diarrhoea—Temozolomide—brain cancer	0.00176	0.002	CcSEcCtD
Milnacipran—Dizziness—Temozolomide—brain cancer	0.0017	0.00194	CcSEcCtD
Milnacipran—Vomiting—Carmustine—brain cancer	0.00169	0.00193	CcSEcCtD
Milnacipran—Gastrointestinal pain—Etoposide—brain cancer	0.00168	0.00192	CcSEcCtD
Milnacipran—Rash—Carmustine—brain cancer	0.00167	0.00191	CcSEcCtD
Milnacipran—Dermatitis—Carmustine—brain cancer	0.00167	0.00191	CcSEcCtD
Milnacipran—Headache—Carmustine—brain cancer	0.00166	0.0019	CcSEcCtD
Milnacipran—Vomiting—Temozolomide—brain cancer	0.00163	0.00186	CcSEcCtD
Milnacipran—Urticaria—Etoposide—brain cancer	0.00163	0.00186	CcSEcCtD
Milnacipran—Abdominal pain—Etoposide—brain cancer	0.00162	0.00185	CcSEcCtD
Milnacipran—Body temperature increased—Etoposide—brain cancer	0.00162	0.00185	CcSEcCtD
Milnacipran—Rash—Temozolomide—brain cancer	0.00162	0.00185	CcSEcCtD
Milnacipran—Dermatitis—Temozolomide—brain cancer	0.00162	0.00185	CcSEcCtD
Milnacipran—Headache—Temozolomide—brain cancer	0.00161	0.00183	CcSEcCtD
Milnacipran—Nausea—Carmustine—brain cancer	0.00158	0.0018	CcSEcCtD
Milnacipran—Nausea—Temozolomide—brain cancer	0.00152	0.00174	CcSEcCtD
Milnacipran—Hypersensitivity—Etoposide—brain cancer	0.00151	0.00173	CcSEcCtD
Milnacipran—Asthenia—Etoposide—brain cancer	0.00147	0.00168	CcSEcCtD
Milnacipran—Pruritus—Etoposide—brain cancer	0.00145	0.00166	CcSEcCtD
Milnacipran—Diarrhoea—Etoposide—brain cancer	0.0014	0.0016	CcSEcCtD
Milnacipran—Dizziness—Etoposide—brain cancer	0.00136	0.00155	CcSEcCtD
Milnacipran—Vomiting—Etoposide—brain cancer	0.00131	0.00149	CcSEcCtD
Milnacipran—Rash—Etoposide—brain cancer	0.00129	0.00148	CcSEcCtD
Milnacipran—Dermatitis—Etoposide—brain cancer	0.00129	0.00148	CcSEcCtD
Milnacipran—Headache—Etoposide—brain cancer	0.00129	0.00147	CcSEcCtD
Milnacipran—Nausea—Etoposide—brain cancer	0.00122	0.00139	CcSEcCtD
